SUN C5174Alternative Names: SUN C 5174
Latest Information Update: 18 Jun 2002
At a glance
- Originator Suntory
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Serotonin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Arterial occlusive disorders
Most Recent Events
- 18 Jun 2002 Discontinued - Phase-II for Arterial occlusive disorders in Japan (PO)
- 17 Aug 2000 Phase-II clinical trials for Arterial occlusive disorders in Japan (PO)
- 22 Oct 1999 New profile